List of SBIR/STTR awards granted to Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41HL147640-01A1 | Phase I | 225,000 | September 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2017 for $1,541,545.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA206788-02 | Phase II | 1,541,545 | September 14, 2017 | |||||||
A SBIR Phase II contract was awarded to Navidea Biopharmaceuticals, Inc. in April, 2015 for $1,500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA180390-02 | Phase II | 1,500,000 | April 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. in August, 2015 for $321,838.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL127846-01 | Phase I | 321,838 | August 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2014 for $2,032,234.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AG045990-02 | Phase II | 2,032,234 | September 1, 2014 | |||||||
A SBIR Phase II contract was awarded to Navidea Biopharmaceuticals, Inc. in August, 2016 for $1,500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AR067583-02 | Phase II | 1,500,000 | August 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2014 for $1,572,900.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AG044130-02 | Phase II | 1,572,900 | September 1, 2014 | |||||||
A SBIR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2015 for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA192859-01A1 | Phase I | 300,000 | September 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. in July, 2015 for $224,993.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AR067583-01A1 | Phase I | 224,993 | July 3, 2015 | |||||||
A SBIR Phase II contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2016 for $1,500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA192859-02 | Phase II | 1,500,000 | September 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. in May, 2016 for $232,464.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA206788-01 | Phase I | 232,464 | May 27, 2016 | |||||||
A SBIR Phase II contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2015 for $1,226,270.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA162783-02 | Phase II | 1,226,270 | September 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. for $315,217.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA162783-01A1 | Phase I | 315,217 | ||||||||
A SBIR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. for $258,824.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG044130-01 | Phase I | 258,824 | ||||||||
A SBIR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. for $151,814.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG045990-01 | Phase I | 151,814 | ||||||||
A SBIR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. for $165,917.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA180390-01A1 | Phase I | 165,917 |
